ArticleAmerican journal of nephrology2018

Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.

Rajiv Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.